ArticleCirculation. Heart failure2022

Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy.

Perry Elliott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.